品名: (3S,10S,14S)-1-((1r,4S)-4-(氨基甲基)环己基)-3-(萘-2-基甲基)-1,4,12-三氧杂-2,5,11,13-四氮杂十六烷-10,14,16-三羧酸
CAS: 1703768-74-4
包装: 100mg,50mg,250mg
价格: 面议、电联、微信、QQ
产地: 中国上海
最后更新: 2026-01-20 08:44:56
| 中文名 | (3S,10S,14S)-1-((1r,4S)-4-(氨基甲基)环己基)-3-(萘-2-基甲基)-1,4,12-三氧杂-2,5,11,13-四氮杂十六烷-10,14,16-三羧酸 |
| 英文名 | Vipivotide tetraxetan Linker |
| 别名 | (3S,10S,14S)-1-((1r,4S)-4-(氨基甲基)环己基)-3-(萘-2-基甲基)-1,4,12-三氧杂-2,5,11,13-四氮杂十六烷-10,14,16-三羧酸 |
| CAS | 1703768-74-4 |
| EINECS | |
| 化学式 | C33H45N5O9 |
| 分子量 | 655.74 |
| inchi | |
| 包装信息 | 100 mg |
| 价格 | $1,999 |
| 产品描述 | (3S,10S,14S)-1-((1r,4S)-4-(氨基甲基)环己基)-3-(萘-2-基甲基)-1,4,12-三氧杂-2,5,11,13-四氮杂十六烷-10,14,16-三羧酸 JUN68744 is a useful peptide linker for synthesis of PSMA-617 (vipivotide tetraxetan), which is a ligand used to make 177Lu-PSMA-617, a radioactive molecule to fight cancer. PSMA-617 originally was developed at the German Cancer Research Center and the Heidelberg University Hospital. ABX held the exclusive license to bring the treatment, which targets prostate-specific membrane antigen (PSMA), through early clinical development. |
| 产品链接 | http://adc.bocsci.com/product/jun68744-cas-1703768-74-4-291924.html |
| 更新日期 | 2025-04-30 11:27:47 |